NCT05416307Phase 2, phase 3Recruiting

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Study sponsor: Electra Therapeutics Inc. · ETRA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-03Estimated
Enrollment · participants156Estimated
Source updated2026-10-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jun 2027. After: Mar 2028.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview